Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ARG1 | P05089 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.54 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.54 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.54 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.54 |
| ▸ | DPP4 | P27487 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | THRB | P10828 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.44 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.44 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.44 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.44 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.44 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.44 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1476315 | 1.00 | ARG1 (0.59) | ARG1CYP1A2ALOX15CYP2C19CYP2D6 | |
| SCHEMBL4302105 | 1.00 | ARG1 (0.59) | ARG1CYP1A2ALOX15CYP2C19CYP2D6 | |
| SCHEMBL3675363 | 1.00 | ARG1 (0.59) | ARG1CYP1A2ALOX15CYP2C19CYP2D6 | |
| SCHEMBL3676541 | 1.00 | ARG1 (0.59) | ARG1CYP1A2ALOX15CYP2C19CYP2D6 | |
| SCHEMBL1512874 | 1.00 | ARG1 (0.59) | ARG1CYP1A2ALOX15CYP2C19CYP2D6 | |
| SCHEMBL1512877 | 1.00 | ARG1 (0.59) | ARG1CYP1A2ALOX15CYP2C19CYP2D6 | |
| Hydrochloric Acid SCHEMBL1914280 | 0.98 | ARG1 (0.58) | ARG1CYP1A2ALOX15CYP2C19CYP2D6 | |
| SCHEMBL7537502 | 0.82 | ARG1 (0.44) | ARG1CYP1A2ALOX15CYP2C19CYP2D6 | |
| SCHEMBL7694066 | 0.81 | ARG1 (0.44) | ARG1CYP1A2ALOX15CYP2C19CYP2D6 | |
| SCHEMBL4950542 | 0.81 | ARG1 (0.58) | ARG1CYP1A2ALOX15CYP2C19CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250295157-A1 | METHODS FOR THE IMPROVEMENT AND MAINTENANCE OF WEIGHT LOSS | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2025-09-25 | — | — | US | disclosed |
| US-12349713-B2 | Methods for the improvement and maintenance of weight loss | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2025-07-08 | — | — | US | disclosed |
| EP-4099849-A1 | COMPOSITIONS AND METHODS FOR THE IMPROVEMENT AND MAINTENANCE OF GLUCOSE METABOLISM IN CHILDHOOD AND ADOLESCENCE | Société des Produits Nestlé S.A. (CH) | 2022-12-14 | — | — | EP | disclosed |
| US-20220369685-A1 | COMPOSITIONS AND METHODS FOR THE IMPROVEMENT AND MAINTENANCE OF GLUCOSE METABOLISM IN CHILDHOOD AND ADOLESCENCE | NESTLE SA (CH) | 2022-11-24 | — | — | US | disclosed |
| US-20220338521-A1 | COMPOSITIONS AND METHODS FOR THE IMPROVEMENT AND MAINTENANCE OF WEIGHT LOSS | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2022-10-27 | — | — | US | disclosed |
| CN-114980753-A | Compositions and methods for improving and maintaining glucose metabolism in children and adolescents | 雀巢产品有限公司 | 2022-08-30 | — | — | CN | disclosed |
| CN-114423304-A | Compositions and methods for improvement and maintenance of weight loss | 雀巢产品有限公司 | 2022-04-29 | — | — | CN | disclosed |
| WO-2021156181-A1 | COMPOSITIONS AND METHODS FOR THE IMPROVEMENT AND MAINTENANCE OF GLUCOSE METABOLISM IN CHILDHOOD AND ADOLESCENCE | Société des Produits Nestlé S.A. (CH) | 2021-08-12 | — | — | WO | disclosed |
| EP-3197445-B1 | PROLINE OR PROLINE DERIVATIVES FOR THE TREATMENT OF DEMENTIA | SALAMA ZOSER B (DE) | 2021-04-28 | — | — | EP | disclosed |
| WO-2021058358-A1 | COMPOSITIONS AND METHODS FOR THE IMPROVEMENT AND MAINTENANCE OF WEIGHT LOSS | Société des Produits Nestlé S.A. (CH) | 2021-04-01 | — | — | WO | disclosed |
| US-10328051-B2 | Proline or proline derivatives for the treatment of dementia | SALAMA ZOSER B (DE) | 2019-06-25 | — | — | US | disclosed |
| US-20170239215-A1 | PROLINE OR PROLINE DERIVATIVES FOR THE TREATMENT OF DEMENTIA | SALAMA ZOSER B (DE) | 2017-08-24 | — | — | US | disclosed |
| EP-3197445-A1 | PROLINE OR PROLINE DERIVATIVES FOR THE TREATMENT OF DEMENTIA | Salama, Zoser B. (DE) | 2017-08-02 | — | — | EP | disclosed |
| WO-2016046162-A1 | PROLINE OR PROLINE DERIVATIVES FOR THE TREATMENT OF DEMENTIA | SALAMA ZOSER B (DE) | 2016-03-31 | — | — | WO | disclosed |
| US-7727530-B2 | Anti-cancer composition comprising proline or its derivatives and an anti-tumour antibody | SALAMA ZOSER B | 2010-06-01 | — | — | US | disclosed |
| EP-1765328-A1 | ANTI-CANCER COMPOSITION COMPRISING PROLINE OR ITS DERIVATIVES AND AN ANTI-TUMOUR ANTIBODY | Salama, Zoser B. (DE) | 2007-03-28 | — | — | EP | disclosed |
| WO-2005120495-A1 | ANTI-CANCER COMPOSITION COMPRISING PROLINE OR ITS DERIVATIVES AND AN ANTI-TUMOUR ANTIBODY | SALAMA ZOSER B (DE) | 2005-12-22 | — | — | WO | disclosed |
| US-20050276810-A1 | Anti-cancer composition comprising proline or its derivatives and an anti-tumour antibody | SALAMA ZOSER B | 2005-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10328051-B2 | Proline or proline derivatives for the treatment of dementia | PSEN2, PSEN1, PRNP | ARG1 154/4885CYP1A2 2826/4885ALOX15 2262/4885 |
| US-20170239215-A1 | PROLINE OR PROLINE DERIVATIVES FOR THE TREATMENT OF DEMENTIA | PSEN2, PSEN1, PRNP | ARG1 154/4885CYP1A2 2826/4885ALOX15 2262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.